PTA-News: Dr. Hönle AG: Hönle achieves an operating result of 10.2 million euros in the first six months
Business news for the stock market
Gräfelfing/München (pta009/17.05.2019/08:00) - The Hönle Group's sales revenues decreased by 7.7 % to TEur 55,990 in the first six months of the 2018/2019 financial year compared with the prior-year period. Owing to lower adhesives sales, the operating result (EBIT) decreased from TEur 15,047 to TEur 10,187, which translates into an EBIT margin of 17.6 % (PY: 24.5 %). Earnings before taxes (EBT) contracted from TEur 14,919 to TEur 10,073. After income taxes, the consolidated net income came to TEur 7,151 compared to TEur 10,765 in the previous year. This compares to earnings per share of Eur 1.30 (PY: Eur 1.96). Consequently, net profit on sales dropped from 17.7 % to 12.8 %.
Following a very successful financial year 2017/2018, weaker sales and earnings development is expected for the Adhesives segment in the current financial year, taking a sales shift into account. Moreover, lower sales figures of a key customer will impact adversely on the development of sales. Some adhesives projects that were scheduled for realisation in the present financial year will probably be postponed to the next financial year.
However, in view of the expansion of existing customer relationships and numerous ongoing projects, the Management Board expects strong business development over the medium to long term.
Sales and earnings in the Equipment & Systems segment in the 2018/2019 financial year are expected to be lower than in the previous year. This assessment is based on a continued decrease in order intake, particularly concerning incoming orders from the printing industry.
Positive sales and earnings development is predicted for the Glass and Lamps segment.
A high order backlog at Raesch Quarz (Germany) GmbH will contribute to this development. In addition, higher sales revenues in ballast water sterilisation segment are predicted to lead to a positive business development at UV-Technik Speziallampen GmbH.
The Management continues to assume that the Hönle Group will achieve the lower end of the communicated target range of Eur 115 million to Eur 130 million with respect to sales revenues and Eur 22 million to 30 million as regards the operating result in financial year 2018/2019.
Ongoing projects, in particular in the adhesives segment, indicate that the Hönle Group can surpass the positive financial year 2017/2018 in financial year 2019/2020.
The full half year report is available at:
Dr. Hönle AG is a listed technology company with head office in Gräfelfing, near Munich. With a staff level of about 600 employees, the Hönle Group develops innovative solutions for different industrial production processes. The equipment is used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The company's business activities also include the development and sale of industrial adhesives and sealings. In addition, the group manufactures UV lamps that are used in water sterilisation and for other applications, and produces tubing and semi-finished goods made of quartz glass that are used by various branches of industry. The Hönle Group is represented worldwide in more than 20 countries by own companies and sales partners.
emitter: Dr. Hönle AG
address: Lochhamer Schlag 1, 82166 Gräfelfing/München
contact person: Peter Weinert
phone: +49 89 85608-173
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate